Upregulation of δ-catenin is associated with poor prognosis and enhances transcriptional activity through Kaiso in non-small-cell lung cancer
Article first published online: 10 NOV 2010
© 2010 Japanese Cancer Association
Volume 102, Issue 1, pages 95–103, January 2011
How to Cite
Dai, S.-D., Wang, Y., Zhang, J.-Y., Zhang, D., Zhang, P.-X., Jiang, G.-Y., Han, Y., Zhang, S., Cui, Q.-Z. and Wang, E.-H. (2011), Upregulation of δ-catenin is associated with poor prognosis and enhances transcriptional activity through Kaiso in non-small-cell lung cancer. Cancer Science, 102: 95–103. doi: 10.1111/j.1349-7006.2010.01766.x
- Issue published online: 15 DEC 2010
- Article first published online: 10 NOV 2010
- (Received June 21, 2010/Revised September 27, 2010/Accepted September 29, 2010/Accepted manuscript online October 7, 2010/Article first published online November 10, 2010)
Fig. S1. Sequencing result of plasmid pCMV5-FLAG/δ-catenin.
Fig. S2. Overexpression of δ-catenin and Kaiso in lung cancer tissues.
Fig. S3. The methylated status of MTA2 promoter in A549 and SPC cells.
Fig. S4. Expression of Kaiso and δ-catenin after transfection of their cDNA or siRNA.
Table S1. Correlations between δ-catenin, Kaiso mRNA and clinicopathological factors.
Table S2. Correlations between δ-catenin, Kaiso protein and clinicopathological factors.
Table S3. Correlations between MMP7, cyclin D1 and MTA2 mRNA and clinicopathological factors.
|CAS_1766_sm_Figure1.jpg||247K||Supporting info item|
|CAS_1766_sm_Figure2.jpg||771K||Supporting info item|
|CAS_1766_sm_Figure3.jpg||99K||Supporting info item|
|CAS_1766_sm_Figure4.jpg||194K||Supporting info item|
|CAS_1766_sm_Tables1-3.doc||89K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.